Sun Pharmaceutical Industries Limited is a generic pharmaceutical company that specializes in the development, manufacturing, and marketing of both branded and generic formulations, as well as active pharmaceutical ingredients (APIs). Operating in India and internationally, the company offers a diverse range of formulations across therapeutic areas such as central nervous system, dermatology, cardiology, oncology, ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopedic, nephrology, dental, and others. Sun Pharmaceutical Industries also supplies APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances. Their product portfolio includes generic medications like tablets, capsules, injectables, inhalers, ointments, creams, liquids, specialty medications, and over-the-counter products. The company, founded in 1983, is headquartered in Mumbai, India.
Navigation section
Sun Pharmaceutical Industries Limited
- 1,833.35 -32.75(-1.75%) 1,832.50 -33.40(-1.79%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,829.60 1,830.20 | 1,868.00 1873.80 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 1,068.35 (31-Oct-2023) 1,069.00 (31-Oct-2023) | 1,873.35 (16-Sep-2024) 1,873.80 (18-Sep-2024) |
- Open
- 1,868.00 1,873.80
- Previous Close
- 1,866.10 1,865.90
- Volume
- 12.03
- Total Traded value
- 221.94 (₹ Lakhs)
- Upper circuit
- 2,052.70 1,457.30
- Lower circuit
- 1,679.50 1,192.40
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 105 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 1,836.00 | 105.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 105 |
Fundamentals
| Market Cap: | ₹4,398.82 Cr |
| PE Ratio (TTM): | 164.87 |
| PB Ratio: | 18.90 |
| Industry P/E: | 41.99 |
| Debt to Equity: | - |
| ROE: | 11.46 |
| EPS (TTM): | 11.32 |
| Book Value: | 85.73 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 5,096.21 Cr | 4,466.07 Cr | 5,948.22 Cr | 4,645.75 Cr | 5,285.29 Cr |
| Profit | 888.63 Cr | 380.64 Cr | -1,020.82 Cr | 486.73 Cr | 1,213.01 Cr |
| Expense | 4,296.23 Cr | 4,090.52 Cr | 4,161.00 Cr | 4,207.70 Cr | 4,098.84 Cr |
| Comprehensive income | 855.01 Cr | 403.97 Cr | -979.88 Cr | 499.33 Cr | 1,192.23 Cr |
| EPS | 3.70 | 1.60 | -4.30 | 2.00 | 5.10 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Feb, 1995 Dec, 1994 | Pharmaceuticals Pharmaceuticals | SUNPHARMA SUNPHARMA |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Sun Pharmaceutical Industries Limited FAQ's
What is the range of today's stock performance for Sun Pharmaceutical Industries Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,829.60 on the NSE (National Stock Exchange) to a maximum of 1,868.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,830.20 to a high of 1,873.80.
What are the 52-week low and high values for Sun Pharmaceutical Industries Limited?
The stock's performance over the past 52 weeks reveals a low of 1,068.35 (occurred on 31-Oct-2023) and a high of 1,873.35 (achieved on 16-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,069.00 (on 31-Oct-2023), and the 52-week high is 1,873.80 (on 18-Sep-2024).
What was the opening and previous closing prices for Sun Pharmaceutical Industries Limited?
The stock's performance over the past 52 weeks reveals a low of 1,068.35 (occurred on 31-Oct-2023) and a high of 1,873.35 (achieved on 16-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,069.00 (on 31-Oct-2023), and the 52-week high is 1,873.80 (on 18-Sep-2024).
What is the total volume and traded value for Sun Pharmaceutical Industries Limited for the day?
The total volume is 12, and the total traded value is 221.94 (₹ Lakhs).
What are the upper and lower circuit limits for Sun Pharmaceutical Industries Limited?
The upper circuit limit is 2,052.70, and the lower circuit limit is 1,679.50.
What is the market cap and PE ratio for Sun Pharmaceutical Industries Limited?
The market cap is ₹4,398.82 Cr, and the PE ratio (TTM) is 42.61.
What is the PB ratio, industry P/E, and debt to equity ratio for Sun Pharmaceutical Industries Limited?
The PB ratio is 21.38, industry P/E is 41.99 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Sun Pharmaceutical Industries Limited?
ROE is 11.46, EPS is 11.32, book value is 85.73
What are the revenue and profit figures for the latest quarter and previous quarters for Sun Pharmaceutical Industries Limited?
In Sep 2023, Revenue is ₹50962100000.00, and Profit is ₹8886300000.00. In Jun 2023, Revenue is ₹44660700000.00, and Profit is ₹3806400000.00.
When was Sun Pharmaceutical Industries Limited listed, and what industry does it belong to?
The company, Sun Pharmaceutical Industries Limited, was listed in Feb 1995 and belongs to the Pharmaceuticals industry. Its NSE symbol is SUNPHARMA.
What is the current shareholding pattern of the Sun Pharmaceutical Industries Limited?
As of latest available update, promoters hold 54.48%, the public holds 45.52%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 18
- Threads
- 32
Latest Business News
US Fed cuts interest rate by half percent"Recent indicators suggest that economic activity has continued to expand at a solid pace," the...- NewsBot
- Updated:
-
Samsung employees strike: CITU seeks government intervention to resolve issueChennai, As the strike by employees of Korean electronics giant Samsung entered its tenth day on...
- NewsBot
- Updated:
-
Export of goods, services expected to cross US $ 825 billion in the current financial year: GoyalNew Delhi, Commerce and Industry Minister Piyush Goyal on Wednesday expressed hope that the...
- NewsBot
- Updated:
-
India will ensure adequate charging infrastructure for large-scale EV adoption: KumaraswamyNew Delhi, India will ensure sufficient charging infrastructure to support mass adoption of...
- NewsBot
- Updated:
-
FPI Ministry to organize 'World Food India 2024' from ThursdayNew Delhi, The Ministry of Food Processing Industries will organize its flagship conference...
- NewsBot
- Updated:
- 1 min read